Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs

Files

Access status: Embargo until 2050-01-01 , rissalada_combined_2014.pdf (108.26 KB)

Publication date

2014-04-01

Authors

Risselada, A.J.ISNI 0000000387813014
Mulder, HansISNI 0000000388178892
Heerdink, RobORCID 0000-0002-5946-7209ISNI 0000000394315283
Gregoor, J.G.ISNI 0000000396916939
Gonera, Rob K.
Egberts, ToineORCID 0000-0003-1758-7779ISNI 0000000392745722

Editors

Advisors

Supervisors

Document Type

Letter

License

Abstract

Keywords

leptin, neuroleptic agent, serotonin 2C receptor, gene, gene interaction, genetic association, genetic polymorphism, genotype, HTR2C LEP gene, HTR2C LEPR gene, human, letter, logistic regression analysis, obesity, prevalence, priority journal, schizophrenia, serotoninergic system, weight gain, SDG 3 - Good Health and Well-being

Citation

Risselada, A J, Mulder, H, Heerdink, E R, Gregoor, J G, Gonera, R K & Egberts, T C G 2014, 'Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs', Journal of Clinical Psychopharmacology, vol. 34, no. 2, pp. 266-268. https://doi.org/10.1097/JCP.0000000000000069